Jointechlabs
1 known investors
Jointechlabs develops point-of-care regenerative medicine devices, including the FDA-cleared MiniTC for processing autologous fat into microfat and the CE-marked Mini-Stem System for SVF processing. Its products are used by doctors and clinics for applications such as pain management, orthopedics, sports medicine, aesthetics, reconstruction, and wound healing.
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $219K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.